User menu

Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.

Bibliographic reference Hermans, Michel ; Sacks, Frank M ; Ahn, Sylvie A ; Rousseau, Michel. Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence.. In: Cardiovascular Diabetology, Vol. 10, p. 20 [1-7] (2011)
Permanent URL http://hdl.handle.net/2078.1/132375
  1. Sniderman Allan D., St-Pierre Annie C., Cantin Bernard, Dagenais Gilles R., Després Jean-Pierre, Lamarche Benoît, Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk, 10.1016/s0002-9149(03)00262-5
  2. Sniderman A. D., Non-HDL Cholesterol Versus Apolipoprotein B in Diabetic Dyslipoproteinemia: Alternatives and surrogates versus the real thing, 10.2337/diacare.26.7.2207
  3. Sniderman A. D., Apolipoprotein B Versus Non-High-Density Lipoprotein Cholesterol: And the Winner Is..., 10.1161/circulationaha.105.583336
  4. Denke M. A., Weighing in Before the Fight: Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol Versus Apolipoprotein B as the Best Predictor for Coronary Heart Disease and the Best Measure of Therapy, 10.1161/circulationaha.105.588178
  5. Levinson Stanley S., Comparison of Apolipoprotein B and Non–High-Density Lipoprotein Cholesterol for Identifying Coronary Artery Disease Risk Based on Receiver Operating Curve Analysis, 10.1309/22m22rf48px9ut9t
  6. Walldius Göran, Jungner Ingmar, Holme Ingar, Aastveit Are H, Kolar Werner, Steiner Eugen, High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study, 10.1016/s0140-6736(01)07098-2
  7. Yusuf Salim, Hawken Steven, Ôunpuu Stephanie, Dans Tony, Avezum Alvaro, Lanas Fernando, McQueen Matthew, Budaj Andrzej, Pais Prem, Varigos John, Lisheng Liu, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, 10.1016/s0140-6736(04)17018-9
  8. Sierra-Johnson J., Fisher R. M., Romero-Corral A., Somers V. K., Lopez-Jimenez F., Ohrvik J., Walldius G., Hellenius M.-L., Hamsten A., Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population, 10.1093/eurheartj/ehn347
  9. Garvey W. T., Kwon S., Zheng D., Shaughnessy S., Wallace P., Hutto A., Pugh K., Jenkins A. J., Klein R. L., Liao Y., Effects of Insulin Resistance and Type 2 Diabetes on Lipoprotein Subclass Particle Size and Concentration Determined by Nuclear Magnetic Resonance, 10.2337/diabetes.52.2.453
  10. Kathiresan S., Increased Small Low-Density Lipoprotein Particle Number: A Prominent Feature of the Metabolic Syndrome in the Framingham Heart Study, 10.1161/circulationaha.105.567107
  11. Brunzell J. D., Davidson M., Furberg C. D., Goldberg R. B., Howard B. V., Stein J. H., Witztum J. L., Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation, 10.2337/dc08-9018
  12. Hermans M. P., Levy J. C., Morris R. J., Turner R. C., Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes, 10.2337/diabetes.48.9.1779
  13. Hermans M. P., Levy J. C., Morris R. J., Turner R. C., Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes, 10.1007/s001250051215
  14. Lee S.-J., LDL Containing Apolipoprotein CIII Is an Independent Risk Factor for Coronary Events in Diabetic Patients, 10.1161/01.atv.0000066131.01313.eb
  15. Zheng Chunyu, Khoo Christina, Ikewaki Katsunori, Sacks Frank M., Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions, 10.1194/jlr.p600011-jlr200
  16. Kawakami A., Apolipoprotein CIII in Apolipoprotein B Lipoproteins Enhances the Adhesion of Human Monocytic Cells to Endothelial Cells, 10.1161/circulationaha.105.591743
  17. Hermans Michel P, Ahn Sylvie A, Rousseau Michel F, log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males, 10.1186/1475-2840-9-88